PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsNeoplasm metastasis
MeSH D009362 - neoplasm metastasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009385:Neoplastic processes
1 Company
1 Drug
$
Success rate
D009362: 
Neoplasm metastasis
28 Companies
6 Drugs
$
Success rate
D000079822:Extranodal extension
0 Companies
0 Drugs
Success rate
D008207:Lymphatic metastasis
0 Companies
0 Drugs
Success rate
D009360:Circulating neoplastic cells
0 Companies
0 Drugs
Success rate
D009366:Neoplasm seeding
0 Companies
0 Drugs
Success rate
D009382:Unknown primary neoplasms
0 Companies
0 Drugs
Success rate
D061206:Neoplasm micrometastasis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIbandronic acid Ibandronic Acid Teva  2010-09-17   
Irinotecan Irinotecan  2008-02-27   
SandozIbandronic acid Ibandronic Acid Sandoz  2011-07-26   
Irinotecan Irinotecan  2008-02-27   
BayerLarotrectinib Vitrakvi 2029-10-21 2018-11-26   
RecordatiMechlorethamine Mustargen  1982-01-01   
Helsinn Birex PharmaceuticalsMechlorethamine Valchlor 2026-03-07 2013-08-23   
Mechlorethamine Ledaga  2017-03-03   
AmgenDenosumab Xgeva  2011-07-13 $2,225 M Y2024 
SeagenTucatinib Tukysa  2021-02-11 $374.499 M Q4/22-Q3/23 
Atnahs PharmaceuticalsIbandronic acid Bondronat  1996-06-25   
Novast LaboratoriesIrinotecan Irinotecan  2017-05-26   
CiplaIrinotecan Irinotecan  2008-02-20   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
77%
79/103
Phase 2
37%
49/133
Phase 3
19%
16/84
Approved: 7Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
Larotrectinib,
Salicylic acid,
Gilvetmab,
Aglatimagene besadenovec,
Lenograstim,
Vatalanib,
Regramostim,
Lornoxicam,
Molgramostim,
Bevifimod,
Doxecitine,
Nepidermin,
Rogaratinib,
SAGOPILONE,
Telbermin,
Globulin, immune,
Krestin,
Sagramostim,
Bay1163877,
Histone-arginine methyltransferase carm1,
Gemcis,
Surlorian,
Demand,
Docetaxol,
Ra223,
Taxane,
Primovist
Recordati
Mechlorethamine
Amgen
Denosumab,
Benzocaine,
Motesanib,
Ganitumab,
Trebananib,
Alfacalcidol,
Bevifimod,
CONATUMUMAB,
Corticorelin,
Doxecitine,
Nadide,
Nepidermin,
Polyglycolic acid,
Telbermin,
Insulin,
Retinol,
Globulin, immune,
Bos taurus adrenal cortex corticosteroids,
Anthracycline,
Viaject,
Aminoglycoside,
Doxorubin,
Folinoral,
Histone-arginine methyltransferase carm1,
Hydroxydaunomycin,
Surlorian,
Demand,
Docetaxol,
Fluoropyrimidine,
Taxane
Seagen
Tucatinib,
Cilmostim,
Bevifimod,
Doxecitine,
LADIRATUZUMAB VEDOTIN,
Selicrelumab,
Globulin, immune,
Lactams,
Mk3475,
Taxane
Pfizer
Irinotecan,
Irinotecan hydrochloride,
Irinotecan sucrosofate,
Benzocaine,
Sasanlimab,
Gilvetmab,
Abexinostat,
Tanezumab,
Agatolimod,
Edotecarin,
Lornoxicam,
TEMANOGREL,
Bevifimod,
Doxecitine,
Gedatolisib,
Nepidermin,
Polyglycolic acid,
Ponsegromab,
Globulin, immune,
Ag013736,
Anthracycline,
Endocrine,
Pf03512676,
Pd0332991,
Histone-arginine methyltransferase carm1,
Surlorian,
Docetaxol,
Taxane,
Pf00299804,
Ro5185426
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use